tert-Butyl 3-(4-methoxyphenyl)-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxylate

Catalog No. :
ACNKXR982
CAS No. :
661487-36-1
Molecular Formula :
C18H23N3O3
Molecular Weight :
329.40

IUPAC Name:tert-butyl 3-(4-methoxyphenyl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate

tert-Butyl 3-(4-methoxyphenyl)-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$666.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-(4-methoxyphenyl)-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxylate
IUPAC Nametert-butyl 3-(4-methoxyphenyl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate
MDL No.MFCD08460456
Molecular FormulaC18H23N3O3
Molecular Weight329.40
SMILESO=C(N1CCC(NN=C2C3=CC=C(OC)C=C3)=C2C1)OC(C)(C)C
InChI KeyTXMBDXOQOVGINF-UHFFFAOYSA-N
SynonymTERT-BUTYL 3-(4-METHOXYPHENYL)-6,7-DIHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINE-5(4H)-CARBOXYLATE;5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 1,4,6,7-tetrahydro-3-(4-Methoxyphenyl)-, 1,1-diMethylethyl ester;tert-Butyl 3-(4-methoxyphenyl)-1,4,6,7-tetrahydro-5h-pyrazolo[4,3-c]pyridine-5-carboxylate
CAS No.661487-36-1

Synthetic Route by SureRoute

1. ACNKXR982 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFHVJ839 route compound structure diagram
    ACFHVJ839661487-17-8 In Stock
  2. Plus
  3. ACWPMX482 route compound structure diagram
    ACWPMX482171364-79-7 In Stock
  4. Then
  5. ACNKXR982 route product structure diagram
    ACNKXR982661487-36-1
Inquiry

2. ACNKXR982 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNKXR982 route product structure diagram
    ACNKXR982661487-36-1
Inquiry

Comments (0)